You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 7, July 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (38)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Breast Cancer
 •Surgical Oncology
 •Alert me on articles by topic

The Learning Curve for Sentinel Node Biopsy in Breast Cancer

Practical Considerations

Richard K. Orr, MD, MPH; James L. Hoehn, MD, MS; Nananda F. Col, MD, MPH, MPP

Arch Surg. 1999;134:764-767.

Hypothesis  Performance of sentinel node biopsy (SNB) instead of full axillary lymph node dissection (ALND) by inexperienced surgeons will lead to understaging of some women with breast cancer and increased costs.

Design  A decision analysis model was used to investigate the implications of SNB vs full ALND during the learning phase (60-80 procedures). This model simulates a randomized trial of 10,000 women in each arm. Data regarding the learning curve were obtained from published series.

Main Outcome Measures  Percentage of women with inaccurate staging of their breast cancer, overall survival, quality-adjusted survival, and potential costs of SNB vs ALND.

Results  Performance of SNB instead of ALND results in inability to locate a sentinel node in 38% of attempts during the learning phase (compared with 10% in later cases) and understaging in 12% of patients during the learning phase (compared with 0% in later cases). This understaging is associated with a small decrement in survival (1%-2%) and an increased risk of axillary recurrence. Sentinel node biopsy is cost-effective only when the ability to detect sentinel nodes exceeds 80%; and the cost of SNB is less than 50% of the cost of ALND.

Conclusions  To ensure accurate staging of patients with breast cancer, all surgeons should perform full ALND while learning SNB techniques. Only after documentation of accuracy of SNB (sensitivity >90%) should full ALND be omitted for women with negative sentinel nodes.


From the Department of Surgery, The Marshfield Clinic, Marshfield, Wis, and the University of Wisconsin Medical School, Madison (Drs Orr and Hoehn); and the Division of Clinical Decision Making, Informatics and Telemedicine, New England Medical Center and Tufts University School of Medicine, Boston, Mass (Dr Col).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sentinel Lymph Node Mapping of the Breast
MINIGH
radtech 2008;79:243M-257M.
ABSTRACT | FULL TEXT  

Prospective Comparison of 3 {gamma}-Probes for Sentinel Lymph Node Detection in 200 Breast Cancer Patients
Classe et al.
JNM 2005;46:395-399.
ABSTRACT | FULL TEXT  

Descriptive Review of the Literature on Breast Cancer Outcomes: 1990 Through 2000
Mandelblatt et al.
J Natl Cancer Inst Monogr 2004;2004:8-44.
ABSTRACT | FULL TEXT  

Improving mortality of coronary surgery over first four years of independent practice: retrospective examination of prospectively collected data from 15 surgeons
Bridgewater et al.
BMJ 2004;329:421.
ABSTRACT | FULL TEXT  

Radioguided Sentinel Lymph Node Biopsy in Breast Cancer Surgery
Mariani et al.
JNM 2001;42:1198-1215.
ABSTRACT | FULL TEXT  

The Learning Curve for Sentinel Lymph Node Biopsy in Breast Cancer
Cody III and Orr
Arch Surg 2000;135:605-605.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.